Drug Topics - February 2009 - (Page 26) Issues & Trends PEDIATRIC AND GERIATRIC PHARMACISTS a renowned geriatrician, in every presentation she makes. “When we do presentations to pharmacists, we say, ‘What are the common signs of aging? Confusion, depression, incontinence, blurred vision, dizziness, memory challenges,’” she said. “’Now, let’s talk about common side effects from drugs in seniors: dizziness, confusion, incontinence, blurred vision.’ How do you know which one it is?” Moret said she had expected more pharmacists to take the exam by now as a way to differentiate themselves from pharmacists without particular expertise in geriatrics. But because certification isn’t required by any state board of pharmacy, there hasn’t been a pressing reason for most people to take the test up to this point. Signs indicate that circumstances may be changing. “There are some employers who are now requiring it,” Moret said. “Some of the Medicare Part D prescription drug plans are now asking their pharmacist employees to get the certification, because they need to demonstrate that they know something about this population, who is Medicareeligible, and with unique medication needs.” The geriatric pharmacist also plays a unique role in helping customers distinguish the risks and benefits of herbal supplements and over-the-counter medications, as well. Seniors often fall for scams that can hurt their health, Culbertson said. “A lot of these people are very susceptible to TV advertisements for herbal remedies that may or may not interact with their drugs, so when we talk to them, we have to ask that,” she said. Besides herbal interactions, many elderly aren’t aware over-the-counter medications can contain other medications, Moret said. “[Diphenhydramine] is not a medication that a senior should take,” she said. “But how many seniors take Tylenol PM to help them sleep? Well, diphenhydramine is in it [and] will cause more confusion and dizziness, in addition to affecting gait.” Some pharmacies help their older customers comply with their medication regime by giving them specialized packaging that bundles their medications by the day, rather than distributing them in pill bottles. It’s more expensive, though, which can hurt seniors on fixed incomes. Moret said she’d like to see more geriatric specialty pharmacies, like 50-Plus, open in communities. But even that’s not enough. “We’re more interested in getting all pharmacists to have more expertise in geriatrics,” she adds. For more information on pediatric pharmacy, visit www.ppag.org. For more information on geriatric pharmacy, visit www. ccpg.org. http://www.ppag.org http://www.ccpg.org http://www.ccpg.org
Table of Contents Feed for the Digital Edition of Drug Topics - February 2009 Drug Topics - February 2009 Contents Health-System Edition Group Attempts to Resurrect Pain Care Act HSE Business Management HSE Clinical Letters Up Front Up Front in Depth Community Practice Niche Pharmacies Serve Special Populations Special Report Oral Oncology Drugs New Drugs Update 2008 Approvals OTC New Products Viewpoint Drug Topics - February 2009 Drug Topics - February 2009 - Drug Topics - February 2009 (Page Cover1) Drug Topics - February 2009 - Drug Topics - February 2009 (Page Cover2) Drug Topics - February 2009 - Drug Topics - February 2009 (Page 1) Drug Topics - February 2009 - Drug Topics - February 2009 (Page 2) Drug Topics - February 2009 - Contents (Page 3) Drug Topics - February 2009 - Contents (Page 4) Drug Topics - February 2009 - Contents (Page 5) Drug Topics - February 2009 - Contents (Page 6) Drug Topics - February 2009 - Contents (Page 7) Drug Topics - February 2009 - Contents (Page 8) Drug Topics - February 2009 - Group Attempts to Resurrect Pain Care Act (Page H1) Drug Topics - February 2009 - HSE Business Management (Page H2) Drug Topics - February 2009 - HSE Business Management (Page H3) Drug Topics - February 2009 - HSE Business Management (Page H4) Drug Topics - February 2009 - HSE Business Management (Page H5) Drug Topics - February 2009 - HSE Clinical (Page H6) Drug Topics - February 2009 - HSE Clinical (Page H7) Drug Topics - February 2009 - HSE Clinical (Page H8) Drug Topics - February 2009 - HSE Clinical (Page 9) Drug Topics - February 2009 - HSE Clinical (Page 10) Drug Topics - February 2009 - Letters (Page 11) Drug Topics - February 2009 - Up Front (Page 12) Drug Topics - February 2009 - Up Front (Page 13) Drug Topics - February 2009 - Up Front in Depth (Page 14) Drug Topics - February 2009 - Up Front in Depth (Page 15) Drug Topics - February 2009 - Up Front in Depth (Page 16) Drug Topics - February 2009 - Up Front in Depth (Page 17) Drug Topics - February 2009 - Up Front in Depth (Page 18) Drug Topics - February 2009 - Up Front in Depth (Page 19) Drug Topics - February 2009 - Up Front in Depth (Page 20) Drug Topics - February 2009 - Community Practice (Page 21) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 22) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 23) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 24) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 25) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 26) Drug Topics - February 2009 - Niche Pharmacies Serve Special Populations (Page 27) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 28) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 29) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 30) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 31) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 32) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 33) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 34) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 35) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 36) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 37) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 38) Drug Topics - February 2009 - Special Report Oral Oncology Drugs (Page 39) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 40) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 41) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 42) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 43) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 44) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 45) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 46) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 47) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 48) Drug Topics - February 2009 - New Drugs Update 2008 Approvals (Page 49) Drug Topics - February 2009 - OTC (Page 50) Drug Topics - February 2009 - OTC (Page 51) Drug Topics - February 2009 - OTC (Page 52) Drug Topics - February 2009 - New Products (Page 53) Drug Topics - February 2009 - New Products (Page 54) Drug Topics - February 2009 - New Products (Page 55) Drug Topics - February 2009 - New Products (Page 56) Drug Topics - February 2009 - New Products (Page 57) Drug Topics - February 2009 - New Products (Page 58) Drug Topics - February 2009 - New Products (Page 59) Drug Topics - February 2009 - Viewpoint (Page 60) Drug Topics - February 2009 - Viewpoint (Page Cover3) Drug Topics - February 2009 - Viewpoint (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.